<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201609226105N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-11-14</date_registration>
      <primary_sponsor>Vice Chancellor for Research and Technology of Zahedan University of Medical Sciences</primary_sponsor>
      <public_title>Clinical and radiographic success of pulpotomy in primary molars restored with glass ionomer- crown</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of clinical and radiographic success of pulpotomy in primary molars restored with glass ionomer- crown: A double-blind randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-12-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>55</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/6554</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Dental Caries.</hc_freetext>
      <i_freetext>Intervention 1: Intervention 1&#13;
Applying topical anesthesia gel (TOPEX, Sultan Healthcare IND. CO, USA) for 60 seconds, administration mandibular block anesthesia by delivering 1 mL of lidocaine 2% with epinephrine 1:80000 (Psocaine-E, Darou Pakhsh IND. CO Iran) within 1.5 minutes, rubber dam isolation, caries removal, access cavity preparation with high speed hand piece using water spray, coronal pulp excision using a sharp spoon excavator, rinsing with 5 mL normal saline (Darou Pakhsh IND. CO, Iran) bleeding control and establishing hemostasis with light pressure applying by cotton pellet for 5 minutes, fixing pulp stumps with 1/5 dilution Buckley formocrezole solution (Buckley’s FormoCresol® SultanHealthcare, Hackensack, NJ) for 1 minutes, placing fast setting zinc oxide eugenole (Zoliran, Golchadent CO, Iran) a pulp dressing material, restoring tooth crown at the same appointment by stainless steel crown (3M/ ESPE. St. Paul MN, USA) using luting glass ionomer cement (GC America, Inc., Alsip, IL, USA). Intervention 2: مداخله 2&#13;
اعمال ژل بي حسي موضعي (TOPEX, Sultan Healthcare IND. CO, USA) به مدت 60 ثانيه، انجام بي حسي بلوک منديبل با تزريق 1 ميلي ليتر از محلول ليدوکائين 2% با اپي نفرين 80000/1 (Persocaine-E, Darou Pakhsh IND. CO, Iran) طي زمان 5/1 دقيقه، ایزولاسیون با رابردم، حذف پوسیدگی، تهیه حفره دسترسی با توربین با سرعت بالا و اسپری آب، قطع پالپ تاجی با اکسکاواتور قاشقی تیز، شستشو با 5 میلی لیتر نرمال سالین (Darou Pakhsh IND. CO, Iran)،کنترل خونریزی و ایجاد هموستاز با فشار ملایم گلوله پنبه به مدت 5 دقیقه، فیکس کردن پالپ ناحیه اریفیس با محلول فرموکرزول باکلی (Buckley’s FormoCresol® SultanHealthcare, Hackensack, NJ) با رقت یک پنجم به مدت 1 دقیقه، قرار دادن سمان زینک اکساید اوژنول زود سخت شونده (Zoliran, Golchadent CO, Iran) بعنوان ماده پوشاننده پالپ، ترمیم تاج در همان جلسه با استفاده از گلاس آینومر ترمیمی (GC America, Inc., Alsip, IL, USA) به عنوان ترمیم بازسازی تاج، قرار دادن روکش استینلس استیل (3M/ ESPE. St. Paul MN, USA) با استفاده از سمان گلاس آینومر لوتینگ (GC America, Inc., Alsip, IL, USA).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nahid Ramazani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Azadegan avenue</address>
        <city>9817699691</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9817699691</zip>
        <telephone>+98 54 3341 4005</telephone>
        <email>ramazani_nahid@yahoo.com</email>
        <affiliation>Zahedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nahid Ramazani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Department of Pediatrics</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9817699693</zip>
        <telephone>+98 54 3341 4005</telephone>
        <email>ramazani77@gmail.com</email>
        <affiliation>School of Dentistry</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria :Children between 4-8 years old, require pulpotomy in the primary mandibular second molars, having complete physical and mental health, located in the positive or definitely positive classification of Frankle during behavioral pretreatment assessment, existence of enough crown tissue to repair, nearly the same crown destruction on molars of both sides .&#13;
Exclusion criteria :Any known allergy to medication or anesthetic solution, any emergency situation or tooth pain with pulp-origin .</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>8 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B99-B99</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other and unspecified infectious diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention 1&#13;
Applying topical anesthesia gel (TOPEX, Sultan Healthcare IND. CO, USA) for 60 seconds, administration mandibular block anesthesia by delivering 1 mL of lidocaine 2% with epinephrine 1:80000 (Psocaine-E, Darou Pakhsh IND. CO Iran) within 1.5 minutes, rubber dam isolation, caries removal, access cavity preparation with high speed hand piece using water spray, coronal pulp excision using a sharp spoon excavator, rinsing with 5 mL normal saline (Darou Pakhsh IND. CO, Iran) bleeding control and establishing hemostasis with light pressure applying by cotton pellet for 5 minutes, fixing pulp stumps with 1/5 dilution Buckley formocrezole solution (Buckley’s FormoCresol® SultanHealthcare, Hackensack, NJ) for 1 minutes, placing fast setting zinc oxide eugenole (Zoliran, Golchadent CO, Iran) a pulp dressing material, restoring tooth crown at the same appointment by stainless steel crown (3M/ ESPE. St. Paul MN, USA) using luting glass ionomer cement (GC America, Inc., Alsip, IL, USA).</i_keyword>
      <i_keyword>مداخله 2&#13;
اعمال ژل بي حسي موضعي (TOPEX, Sultan Healthcare IND. CO, USA) به مدت 60 ثانيه، انجام بي حسي بلوک منديبل با تزريق 1 ميلي ليتر از محلول ليدوکائين 2% با اپي نفرين 80000/1 (Persocaine-E, Darou Pakhsh IND. CO, Iran) طي زمان 5/1 دقيقه، ایزولاسیون با رابردم، حذف پوسیدگی، تهیه حفره دسترسی با توربین با سرعت بالا و اسپری آب، قطع پالپ تاجی با اکسکاواتور قاشقی تیز، شستشو با 5 میلی لیتر نرمال سالین (Darou Pakhsh IND. CO, Iran)،کنترل خونریزی و ایجاد هموستاز با فشار ملایم گلوله پنبه به مدت 5 دقیقه، فیکس کردن پالپ ناحیه اریفیس با محلول فرموکرزول باکلی (Buckley’s FormoCresol® SultanHealthcare, Hackensack, NJ) با رقت یک پنجم به مدت 1 دقیقه، قرار دادن سمان زینک اکساید اوژنول زود سخت شونده (Zoliran, Golchadent CO, Iran) بعنوان ماده پوشاننده پالپ، ترمیم تاج در همان جلسه با استفاده از گلاس آینومر ترمیمی (GC America, Inc., Alsip, IL, USA) به عنوان ترمیم بازسازی تاج، قرار دادن روکش استینلس استیل (3M/ ESPE. St. Paul MN, USA) با استفاده از سمان گلاس آینومر لوتینگ (GC America, Inc., Alsip, IL, USA)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Clinical success. Timepoint: 6 months after intervention 1 and 2. Method of measurement: using described criteria of successful clinical treatment including no swelling, tenderness to percussion, tenderness to palpation, mobility, fistula and abscess.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Radiographic success. Timepoint: 6 months after intervention 1 and 2. Method of measurement: using described criteria of successful radiographic treatment including no PDL widening, loss of lamina dura, radiolucency of furcation, internal or external root resorption, supporting bone destruction, pre apical radiolucency.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research and Technology of Zahedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-07-31</approval_date>
        <contact_name>Ethics Committee of Zahedan University of Medical Science</contact_name>
        <contact_address>Zahedan, Persian Gulf Blvd., College, resistance Research and Technology Zahedan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
